Introduction {#sec1}
============

Pluripotent stem cells can generate all cell types of the body and hold great potential for transplantation medicine and the study of early development. Pluripotency arises in the inner cell mass of blastocyst-stage embryos during formation of the epiblast, and both human and mouse blastocysts can give rise to pluripotent embryonic stem cells (ESCs). Differentiation of the pluripotent epiblast toward the primary germ layers occurs after implantation of the embryo during the process of gastrulation. Signaling proteins belonging to the BMP and WNT families are key gastrulation factors that mediate induction of the primitive streak in the embryo and can induce primitive streak derivatives in human ESCs (hESCs) and mouse ESCs (mESCs) ([@bib1; @bib5; @bib10; @bib11; @bib14; @bib26; @bib27; @bib33; @bib43; @bib46]). However, BMP4 additionally induces trophoblast ([@bib11; @bib53]), complicating efforts to obtain single lineages. Furthermore, other reports show that both BMP and WNT signals support the self-renewal of mESCs instead ([@bib20; @bib35; @bib40; @bib47; @bib54]). These conflicting reports may reflect the action of BMP and WNT signals on different pluripotent states, as the epiblast of post implantation mouse embryos can also give rise to a pluripotent cell type, the epiblast stem cell (EpiSC) ([@bib6; @bib48]). EpiSCs are developmentally more advanced than mESCs and possess different morphology, growth factor requirements, gene expression profile, and epigenetic state ([@bib6; @bib48]). They can generate teratomas, a measure of pluripotency, but unlike mESCs are not competent to contribute to blastocyst chimeras.

EpiSCs express many differentiation factors present in the primitive streak ([@bib6; @bib48]) and were found to comprise heterogeneous populations of cells with distinct potency ([@bib4; @bib50]). This suggests that EpiSCs are to some extent prespecified, and their pluripotent state has therefore been designated "primed," as opposed to the unspecified "naïve" pluripotent state of mESCs ([@bib32]). Similar observations were made for hESCs, consistent with them occupying a primed pluripotent state ([@bib5; @bib10; @bib11; @bib41]). Interestingly, for both EpiSCs and hESCs, it has been shown that endogenous WNT proteins, produced by the cells themselves, drive prespecification of the cells ([@bib5; @bib13; @bib44; @bib50]).

Here we address the consequences of endogenous WNT signals for directed differentiation and self-renewal of human and mouse pluripotent cells. We show that endogenous WNT signals mediate differentiation decisions in response to BMP signals and furthermore that they are the main cause of spontaneous differentiation in both hESCs and EpiSCs.

Results {#sec2}
=======

BMP4-Induced Differentiation of EpiSCs Is Mediated by WNT Signals {#sec2.1}
-----------------------------------------------------------------

Both WNT and BMP signals are implicated in the initiation of gastrulation and induction of the primitive streak. To monitor these processes in vitro, we established EpiSCs carrying the T-GFP reporter for the primitive streak marker *Brachyury* by differentiating T-GFP ESCs ([@bib12]) into EpiSCs by culture in FGF2 and ACTIVIN. We included IWP2, a small molecule inhibitor that blocks the biosynthesis of mature WNT proteins ([@bib7]), to increase the efficiency of differentiation ([@bib47]). Phenotypic and functional assays verified the complete differentiation ([Figures S1](#app2){ref-type="sec"}A--S1D available online).

Treatment of the T-GFP EpiSCs with either WNT3A or BMP4, in the presence of ACTIVIN and FGF2, strongly induced reporter expression, followed by loss of the pluripotency marker SSEA1 ([Figure 1](#fig1){ref-type="fig"}A). However, in the BMP4-treated cells, these events were delayed, possibly because BMP4 may act indirectly, by inducing WNT signals in EpiSCs ([Figure 1](#fig1){ref-type="fig"}A). Indeed, BMP4 protein strongly induced a reporter for WNT signaling in Axin2-LacZ EpiSCs ([@bib47]) ([Figure 1](#fig1){ref-type="fig"}B). This was due to the induction of endogenous WNT proteins as reporter expression was inhibited by IWP2 ([Figure 1](#fig1){ref-type="fig"}B). Importantly, IWP2 prevented not only the induction of T-GFP but also the loss of SSEA1 in response to BMP4 ([Figure 1](#fig1){ref-type="fig"}A), suggesting that BMP4-mediated exit from pluripotency requires the activation of WNT. Indeed, while both WNT3A and BMP4 induced expression of differentiation markers and loss of EpiSC markers, IWP2 prevented the gain or loss of these markers in response to BMP4, demonstrating that it relied on the induction of WNT signals ([Figures 1](#fig1){ref-type="fig"}C and [S1](#app2){ref-type="sec"}E). IWP2 did not interfere with WNT signal transduction or differentiation per se since it did not block the effects of WNT3A ([Figure S1](#app2){ref-type="sec"}F).

We used RNA-Seq to analyze the interactions between BMP4 and WNT in EpiSCs treated for 48 hr in the presence of ACTIVIN and FGF2. Principal component analysis showed that the BMP4- and/or WNT3A-treated samples separated from all other samples along the first component, whereas the IWP2-treated samples clustered together, regardless of the presence of BMP4 ([Figure 1](#fig1){ref-type="fig"}D). Interestingly, the WNT3A-treated samples clustered together with the BMP4-treated sample and induced the same mesodermal markers, such as *Kdr*, *Mesp1*, and *Tbx6* ([Figures 1](#fig1){ref-type="fig"}D and 1E). BMP4 was unable to induce these markers in the presence of IWP2 despite inducing the canonical BMP target *Id1*, showing that IWP2 did not interfere with BMP signal transduction ([Figure 1](#fig1){ref-type="fig"}E). These data show that the gene-expression changes induced by BMP4 in EpiSCs are to a large extent secondary to activation of WNT proteins.

Feedback loops between signaling factors are an important element of gastrulation ([@bib2; @bib49]). We therefore analyzed the short-term (2--6 hr) induction of the gastrulation factors *Nodal*, *Wnt3*, and *Fgf8* by BMP4 and/or WNT3A. While BMP4 induced *Wnt3*, WNT3A induced all three factors, and the highest induction of *Wnt3* was obtained using both signals ([Figure 1](#fig1){ref-type="fig"}F). These observations explain why BMP signals are not required for primitive streak induction once WNT signals have been activated. No induction of the WNT target *Axin2* by BMP4 or the BMP-target *Id1* by WNT3A was observed within the 6 hr timeframe ([Figure 1](#fig1){ref-type="fig"}F). However, *Id1* is somewhat induced in the 48 hr WNT3A-only condition, suggesting that the differentiating cells activate endogenous BMP signals ([Figure 1](#fig1){ref-type="fig"}E). Nonetheless, T-GFP induction was not suppressed by the BMP inhibitor LDN193189, indicating that it did not require BMP signals ([Figure 1](#fig1){ref-type="fig"}A). Finally, IWP2 prevented the loss of both OCT4- and SOX2-positive as well as SSEA1-positive EpiSCs in response to BMP4 ([Figures 1](#fig1){ref-type="fig"}G and [S1](#app2){ref-type="sec"}G). Combined, these data indicate that induction of EpiSC differentiation by BMP4 is mediated by the induction of WNT signals.

Endogenous WNT Proteins Induce Differentiation and Loss of Pluripotency in EpiSCs {#sec2.2}
---------------------------------------------------------------------------------

In the course of our studies, we found that T-GFP EpiSCs spontaneously induced a significant GFP-positive population ([Figure 1](#fig1){ref-type="fig"}A, +vehicle). This induction was suppressed either by IWP2 or by the WNT antagonist FZ8CRD, a soluble domain of the WNT receptor that binds and sequesters WNT proteins, indicating that it was due to endogenous WNT proteins ([Figure 1](#fig1){ref-type="fig"}A). The presence of endogenous WNT activity was further confirmed by the spontaneous LACZ activity evident in Axin2-LacZ EpiSCs, which was also suppressed by IWP2 ([Figure 1](#fig1){ref-type="fig"}B). Moreover, multiple *Wnt* genes were expressed in EpiSCs, in particular *Wnt3* ([Figure S2](#app2){ref-type="sec"}A). These observations are in line with a recent report showing that endogenous WNT signals specify a fraction of EpiSCs toward primitive-streak lineages ([@bib50]). Clonal assays showed that these specified cells were not committed to differentiation and maintained a pluripotent phenotype ([@bib50]).

However, we noticed that the GFP-positive cells showed a shift to lower SSEA1 expression, suggesting that some of them lost pluripotency ([Figure 1](#fig1){ref-type="fig"}A). We therefore sorted the cells based on T-GFP intensity and assessed their potential to establish colonies or to form embryoid bodies (EBs), both measures of pluripotency. A clear negative correlation was visible between the level of GFP and potential to establish NANOG-positive colonies ([Figures 2](#fig2){ref-type="fig"}A, [S2](#app2){ref-type="sec"}B, and S2C). Likewise, cells with higher levels of GFP produced smaller EBs, while the cells with the highest level failed to form EBs at all ([Figures 2](#fig2){ref-type="fig"}B and [S2](#app2){ref-type="sec"}D). Moreover, these cells downregulated SOX2 and OCT4 ([Figure 2](#fig2){ref-type="fig"}B). These data show that the T-GFP-positive population is enriched for cells that have lost pluripotency.

We next tested whether WNT inhibition would prevent this loss of pluripotency. When analyzed for SSEA1, multiple EpiSC lines all displayed substantial levels of SSEA1-negative cells, indicating significant differentiation ([Figures 2](#fig2){ref-type="fig"}C and [S2](#app2){ref-type="sec"}E, vehicle). However, in the presence of IWP2, more than 90% of the cells expressed SSEA1 ([Figures 2](#fig2){ref-type="fig"}C and [S2](#app2){ref-type="sec"}E). In addition, RT-PCR and immunostaining showed that IWP2 not only repressed primitive streak markers but also raised the level of the pluripotency markers *Oct4*, *Nanog*, and *Sox2* ([Figures 2](#fig2){ref-type="fig"}D and [S1](#app2){ref-type="sec"}E). Moreover, IWP2 substantially enhanced the expansion of OCT4- and SOX2-positive or SSEA1-positive cells ([Figures 1](#fig1){ref-type="fig"}G and [S1](#app2){ref-type="sec"}G). In line with a recent report ([@bib44]), suppression of endogenous WNT signals also greatly enhanced the derivation of novel EpiSC lines from 25% (four lines from 16 E5.5 embryos) to 79% (15 of 19). These data show that endogenous WNT signals induce loss of pluripotency in a subset of EpiSCs, and WNT inhibition suppresses this spontaneous differentiation, greatly enhancing their self-renewal and derivation efficiency. In fact, certain cell lines, e.g., the T-GFP EpiSCs, could essentially not be maintained in the absence of IWP2 as they progressively accumulated differentiated cells ([Figure 1](#fig1){ref-type="fig"}A, +vehicle).

To identify the differentiation pathways induced by endogenous WNT signals we compared the transcriptomes of EpiSCs maintained in the presence or absence of IWP2. Most differences were due to a set of genes that was repressed by IWP2 ([Figure 2](#fig2){ref-type="fig"}E), with 321 genes downregulated and 87 genes upregulated in response to IWP2 ([Table S1](#mmc2){ref-type="supplementary-material"}). Using gene set enrichment analysis ([@bib42]), we found that a set of 29 genes first expressed around the start of gastrulation ([@bib38]) was strongly enriched in conventional EpiSCs when compared with EpiSCs treated with IWP2 ([Figure 2](#fig2){ref-type="fig"}F; [Table S2](#mmc3){ref-type="supplementary-material"}). We next looked for signatures of more committed cell types that derive from the primitive streak. A set of 98 genes expressed in committed human- and mouse-definitive endoderm and endoderm precursors ([@bib22; @bib30; @bib34; @bib45]) was highly enriched in conventional EpiSCs ([Figure 2](#fig2){ref-type="fig"}F; [Table S3](#mmc4){ref-type="supplementary-material"}). Since some of these genes are also expressed in mesoderm progenitors, we created a gene set consisting of 154 genes specifically expressed in E7.5 endoderm versus mesoderm and ectoderm ([@bib17]) and found strong enrichment of this set in conventional EpiSCs ([Figure 2](#fig2){ref-type="fig"}F; [Table S4](#mmc5){ref-type="supplementary-material"}). Furthermore, a panel of genes associated with the committed endoderm state showed consistent repression in response to IWP2 ([Figure 2](#fig2){ref-type="fig"}G). In contrast, a set of 155 genes expressed in E7.5 mesoderm and ectoderm versus endoderm ([@bib17]) showed no enrichment ([Figure 2](#fig2){ref-type="fig"}F; [Table S5](#mmc6){ref-type="supplementary-material"}) and committed mesoderm markers such as *Mesp1*, *Meox1*, *Kdr*, *Hand1*, *Msgn1*, *Foxf1a*, *Tlx2*, or *Tbx6* ranked low in the comparison ([Table S5](#mmc6){ref-type="supplementary-material"}). Anterior neurectoderm genes did not increase in response to IWP2 ([Figure S2](#app2){ref-type="sec"}F), indicating that endogenous WNT signals were not required to inhibit neural differentiation. These findings show that endogenous WNT signals induce a committed definitive endoderm state in a subset of EpiSCs, explaining the loss of pluripotency in response to endogenous WNT signals.

WNT Inhibition Maintains EpiSCs in a Pregastrula Epiblast Stage {#sec2.3}
---------------------------------------------------------------

Despite their origin from the pregastrula epiblast, transcriptome comparisons indicate that EpiSCs are more similar to the late-gastrula-stage epiblast ([@bib25]). To test whether WNT inhibition maintains EpiSCs in a state closer to that of the pregastrula epiblast, we compared their transcriptomes with those of epiblasts derived from embryos ranging from the cavity (Cav) stage to the prestreak (PS), late mid streak (LMS), late streak (LS), no bud (OB), early bud (EAB), and late bud (LB) stage, obtained using Illumina bead-chip arrays ([@bib25]). A normalization procedure matched the distribution of the expression values from our Affymetrix to the Illumina platform, and the genes that were at least 1.5-fold differentially expressed in response to IWP2 (1,066 gene identifications shared between both platforms) were analyzed using principal component analysis. As observed before ([@bib25]), the first component separated the embryo-derived samples from the EpiSCs, whereas the second component separated the embryo-derived samples according to their developmental stage ([Figure 3](#fig3){ref-type="fig"}A). Importantly, while the regular EpiSCs aligned at the early bud stage, EpiSCs maintained in the presence of IWP2 aligned between the prestreak and early-streak stages, showing that their transcriptome is indeed more similar to that of the pregastrula epiblast ([Figure 3](#fig3){ref-type="fig"}A).

We tested the pregastrula state of EpiSCs maintained with IWP2 using two functional assays. First, a small percentage of EpiSCs can revert to the ESC state when transferred to ESC conditions ([@bib16]), and we found that IWP2 treatment strongly raised this reversal efficiency ([Figure 3](#fig3){ref-type="fig"}B). This indicates that IWP2 caused many more cells to occupy a state of pluripotency sufficiently close to that of ESCs to make the transition. Second, in contrast to epiblast from the gastrula, the pregastrula epiblast can contribute to chimeras upon blastocyst injection ([@bib15]). However, EpiSCs rarely contribute to blastocyst chimeras but rather, corresponding to their late-gastrula stage character, can integrate when introduced into the primitive streak ([@bib23; @bib25]). We derived EpiSCs from E6.5 transgenic embryos carrying either a Rosa26-LacZ or Actin-GFP reporter in the presence of IWP2, cultured the cells for five passages, and performed blastocyst injections. We obtained 3 chimeras out of 14 E10.5 embryos from the Rosa26-LacZ EpiSCs, and 1 chimera out of 14 embryos from the Actin-GFP-derived EpiSC line GFP9 ([Figure 3](#fig3){ref-type="fig"}C). X-gal and immunostainings demonstrated integration into multiple tissues, including the neural tube, somite, nephrogenic cord, body wall, splanchnopleure, and parts of the gut tube ([Figure S3](#app2){ref-type="sec"}A). Together, these tests strongly support the pregastrula character of EpiSCs shielded from WNT signals. Moreover, they indicate that the ability to contribute to blastocyst chimeras does not distinguish naive from primed pluripotent cells.

We considered several explanations for the blastocyst compatibility of IWP2-treated EpiSCs. First, some cells may be reprogrammed to the naive state. However, IWP2 induced no increase in *Tbx3*, *Dppa3*, *Zfp42*, *Klf4*, *Dppa5*, or other naive markers ([Figure 3](#fig3){ref-type="fig"}D; [Table S1](#mmc2){ref-type="supplementary-material"}). Second, IWP2 may stabilize a minor fraction of EpiSCs that contributes to blastocyst chimeras, marked by the Oct4-GFP reporter GOF18 ([@bib19]). IWP2 did however not enhance the GFP-positive fraction and sorted GFP-positive cells lost GFP expression regardless of the presence of IWP2 ([Figures S3](#app2){ref-type="sec"}B and S3C). Third, E-CADHERIN overexpression allows EpiSCs to participate in blastocyst chimeras ([@bib36]). We observed higher *E-cadherin* expression and strong E-CADHERIN staining throughout the cultures in the presence of IWP2, similar in strength as in ESCs, whereas staining was faint and patchy in regular EpiSCs ([Figures 3](#fig3){ref-type="fig"}E and 3F). Furthermore, WNT3A induced the *E-cadherin* repressor *Snai1* and *N-cadherin* and downregulated *E-cadherin* in EpiSCs ([Figure 3](#fig3){ref-type="fig"}G). These observations indicate that endogenous WNT proteins repress *E-cadherin* in EpiSCs, thereby reducing their ability to integrate in the pregastrulation epiblast.

WNT inhibition repressed multiple differentiation genes, including *Eomes*, *Foxa2*, *Gata6*, *Lefty2*, and *Sox17*, to the same level as in ESCs, indicating that they are not EpiSC markers ([Figure 3](#fig3){ref-type="fig"}D). We screened our gene expression data for potential markers for genuine EpiSCs, maintained in the presence of WNT inhibition ([Figure 3](#fig3){ref-type="fig"}H), and identified CD38, CD107/KIT, CD105/ENDOGLIN, and CD44 as cell surface markers suitable to separate ESCs and EpiSCs by flow cytometry ([Figure 3](#fig3){ref-type="fig"}I) and OCT6 as a nuclear marker for genuine EpiSCs ([Figure 3](#fig3){ref-type="fig"}J).

Next, we addressed whether the differentiation-inducing effect of WNT on EpiSCs explains the conflicting reports on the role of WNT in ESCs. While we previously demonstrated that endogenous WNT signals support ESC self-renewal by inhibiting their differentiation into EpiSCs ([@bib47]), we and others also demonstrated that WNT signals induce differentiation of ESCs in EBs ([@bib33; @bib46]). However, a transient EpiSC signature has been detected in differentiating EBs ([@bib55]). This could be the result of a shutdown of the WNT pathway in EBs, which would induce differentiation of ESCs into EpiSCs. When we generated EBs from ESCs carrying the 7xTcf-GFP reporter for WNT signaling ([@bib46]), we observed rapid downregulation of the WNT reporter, followed by loss of the ESC marker CD31 ([Figure 3](#fig3){ref-type="fig"}K). However, the cells maintained expression of the pluripotency marker SSEA1, suggesting they converted into EpiSCs. Following this transition, the WNT reporter was induced while SSEA1 was lost ([Figure 3](#fig3){ref-type="fig"}K), suggesting that endogenous WNTs now acted as differentiation signals. Indeed, using T-GFP ESCs, we observed induction of the differentiation reporter following the transition of the ESCs into EpiSCs ([Figure 3](#fig3){ref-type="fig"}K). Thus, EBs first mediate the conversion of ESCs into EpiSCs; only then are endogenous WNT signals activated that induce their differentiation.

Inhibition of Endogenous WNT Signals Prevents the Accumulation of Differentiated Cells in hESC Cultures {#sec2.4}
-------------------------------------------------------------------------------------------------------

It is thought that hESCs occupy a state of primed pluripotency like that of mouse EpiSCs, rather than the naive pluripotency of mESCs ([@bib32]). hESC cultures experience substantial spontaneous differentiation and require frequent manual removal of accumulations of differentiated cells. We investigated whether commitment to differentiation could be prevented by inhibition of endogenous WNT signals, similar to what we showed for EpiSCs.

In the presence of IWP2 or FZ8CRD, both H1 and H9 hESCs established flatter, sharper edged colonies with very little evidence of differentiated cells, whether cultured on mouse embryo fibroblasts (MEFs) or in mTESR1, a serum- and feeder-free medium ([Figures 4](#fig4){ref-type="fig"}A and [S4](#app2){ref-type="sec"}A). When cultured in standard conditions, both H1 and H9 hESCs formed patches of BRACHYURY- and GATA4-positive cells ([Figures S4](#app2){ref-type="sec"}B and S4C), and significant proportions of the cells lacked NANOG, OCT4, or SOX2 ([Figures 4](#fig4){ref-type="fig"}B and [S4](#app2){ref-type="sec"}D). In contrast, no BRACHYURY or GATA4 was visible when the cells were cultured in the presence of IWP2 ([Figures S4](#app2){ref-type="sec"}B and S4C), and the proportion of cells lacking the pluripotency factors was strongly reduced ([Figures 4](#fig4){ref-type="fig"}B and [S4](#app2){ref-type="sec"}D). A recently introduced defined medium, E8, performed better yet IWP2 significantly improved the proportion of cells expressing the pluripotency factors ([Figure 4](#fig4){ref-type="fig"}B). RT-PCR analysis confirmed that IWP2 repressed multiple markers of mesendodermal differentiation and enhanced expression of pluripotency markers, while neurectodermal markers either showed minor changes or were downregulated ([Figures 4](#fig4){ref-type="fig"}C and [S4](#app2){ref-type="sec"}E). These data suggest that WNT inhibition prevents the spontaneous mesendodermal differentiation of hESCs, while not increasing neurectodermal differentiation.

We next tested whether WNT inhibition obviated the need for manual removal of differentiated cells during routine culture of hESCs. With manual cleaning, both H1 and H9 hESCs maintained persistent populations of cells lacking one or more of the pluripotency factors, while in the absence of cleaning this population progressively increased ([Figures 4](#fig4){ref-type="fig"}D, [S4](#app2){ref-type="sec"}F, and S4H). Strikingly, IWP2 maintained pluripotency factor expression in most cells in the absence of cleaning ([Figures 4](#fig4){ref-type="fig"}D, [S4](#app2){ref-type="sec"}F, and S4H). Furthermore, IWP2 prevented the accumulation of cells expressing the hESC differentiation marker SSEA1, which otherwise rapidly accumulated ([Figures 4](#fig4){ref-type="fig"}E, [S4](#app2){ref-type="sec"}G, and S4H). Finally, both H1 and H9 cells cultured for 10 passages in IWP2 efficiently formed teratomas, indicating that they retained their pluripotency ([Figure S4](#app2){ref-type="sec"}I). Combined, these data show that inhibition of endogenous WNT signals prevents the accumulation of differentiated cells in hESC cultures and obviates the need for their manual removal.

BMP4 Induces Both WNT-Dependent and WNT-Independent Differentiation Pathways in hESCs {#sec2.5}
-------------------------------------------------------------------------------------

We next investigated whether WNT signals mediate BMP-induced differentiation in hESCs. Similar to the observations with mouse EpiSCs, both WNT3A and BMP4 protein induced BRACHYURY and GATA4 in H1 hESCs, with concomitant loss of OCT4 ([Figure S5](#app2){ref-type="sec"}A). Flow cytometry indicated a strong induction of the mesoderm marker ROR2 ([@bib11]), together with suppression of pluripotency factors ([Figures 5](#fig5){ref-type="fig"}A, [S5](#app2){ref-type="sec"}B, and S5C). RT-PCR analysis showed induction of additional primitive streak and mesoderm markers ([Figure 5](#fig5){ref-type="fig"}B). Furthermore, induction of *WNT3* in response to BMP4 suggested that in hESCs too mesodermal induction was mediated by endogenous WNT ([Figure 5](#fig5){ref-type="fig"}C). Indeed, IWP2 prevented mesodermal induction in response to BMP4 ([Figures 5](#fig5){ref-type="fig"}A, 5B, and [S5](#app2){ref-type="sec"}A). IWP2 did not abolish the induction of *WNT3*, indicating that it did not directly interfere with BMP4 signaling ([Figure 5](#fig5){ref-type="fig"}C). Importantly, IWP2 reduced but did not prevent the loss of the pluripotency markers in response to BMP4 ([Figures 5](#fig5){ref-type="fig"}D and [S5](#app2){ref-type="sec"}C). These data show that BMP4 induces mesodermal lineages in hESCs indirectly, via induction of WNT proteins, but also suggest that it induces an alternative differentiation pathway that is WNT independent.

In addition to mesodermal lineages, hESCs have the ability to differentiate into trophoblast ([@bib37; @bib53]), and it has recently been shown that a mixture of mesoderm- and trophoblast-committed cells emerge in response to BMP4 ([@bib11]). In agreement with this study, both flow cytometry for the trophoblast surface marker APA ([@bib11]), and RT-PCR for the trophoblast markers *KRT7*, *ENPEP*, *CGA*, and *GCM1* show that BMP4 induces the emergence of trophoblast progenitors ([Figures 5](#fig5){ref-type="fig"}E, 5F, and [S5](#app2){ref-type="sec"}D). Importantly, WNT3A did not induce trophoblast differentiation, nor was the induction of the trophoblast markers by BMP4 inhibited by IWP2 ([Figures 5](#fig5){ref-type="fig"}E and 5F). Combined, these data show that BMP4 can induce the emergence of trophoblast-committed cells from hESCs in a WNT-independent manner, whereas the induction of mesoderm-committed cells requires the action of WNT proteins, either induced endogenously by BMP4 or added directly to the cells.

Finally, a reasonable assumption would be that hESCs maintained in the presence of IWP2 are better substrates for differentiation as they contribute fewer undesired lineages to the population. Indeed, when differentiated toward trophoblast by BMP4+IWP2, H1 hESCs that were maintained in the presence of IWP2 produced more APA+ cells than regular H1 cells ([Figures 5](#fig5){ref-type="fig"}G and [S5](#app2){ref-type="sec"}E).

Discussion {#sec3}
==========

This work shows that endogenous WNT signals are major hidden factors in the differentiation of hESCs and EpiSCs and affect the outcome of directed differentiation protocols in hitherto unappreciated ways. We show that WNT signals induce the main gastrulation factors *Nodal*, *Wnt3*, and *Fgf8* and are required and sufficient for the induction of mesoderm by the commonly used mesoderm inducer BMP4. A surprising finding is that BMP4 induces both mesoderm as well as trophoblast-committed cells from hESCs, but only mesoderm induction requires the activation of *WNT* genes by BMP4.

We further show that endogenous WNT signals interfere with self-renewal of hESCs and mEpiSCs. Endogenous WNTs push the aggregate developmental phenotype of EpiSCs to that reminiscent of late-gastrula stage epiblast, consisting of a mixture of genuine EpiSCs with cells in various stages of differentiation, including cells committed to the definitive endoderm lineage. WNT inhibition prevents the induction of differentiation genes and commitment to endoderm, thereby maintaining a high percentage of genuine EpiSCs displaying their pregastrula phenotype, as evidenced by their contribution to blastocyst chimeras. A similar process takes place in hESCs, where we show that WNT inhibition is so effective in suppressing differentiation that it obviates the need for manual removal of differentiated cells during routine culture.

These findings are summarized in [Figure 6](#fig6){ref-type="fig"}, and they have obvious ramifications for the guided differentiation of hESCs. For instance, to induce trophoblast one should stimulate with BMP4 in the presence of a WNT inhibitor to avoid induction of mesoderm. Conversely, mesoderm is best obtained using WNT3A in lieu of BMP4 to avoid trophoblast induction. Furthermore, WNT-inhibited hESCs differentiate more efficiently to the trophoblast lineage, suggesting that genuine EpiSCs and hESCs, maintained as homogeneous undifferentiated populations by WNT inhibition, are superior substrates for differentiation as they contribute fewer undesired lineages to the population. We also find that different cell lines and culture media display various tendencies for endogenous WNT-induced differentiation, affecting their suitability for specific purposes such as mesoderm or neural differentiation. This may also influence to what extent WNT inhibition supports their self-renewal or improves their subsequent differentiation. Another interesting observation is that spontaneous endogenous WNT signals induce endoderm in EpiSCs, consistent with the finding that low levels of WNT3A (25 ng/ml) induce definitive endoderm ([@bib9]), whereas high levels of WNT3A (250 ng/ml) induce mesoderm. This may reflect a later function for WNT in redirecting primitive streak-specified cells from endoderm to mesoderm ([@bib29]). Finally, ESCs are commonly aggregated into EBs for the derivation of mesendodermal lineages. We now show that EBs mediate the transition of mESCs into EpiSCs, which is followed by activation of an endogenous WNT gradient and primitive streak induction ([@bib46]). A more controlled way of inducing mesendodermal lineages would be by directly inducing genuine EpiSCs with defined levels of WNT signals.

The sequential action of BMP and WNT signals that we uncover here is consistent with embryological findings: *Bmp4* is expressed prior to gastrulation in the extraembryonic ectoderm ([@bib51]), both *Wnt3* and active beta-catenin have been detected in the prestreak epiblast bordering this *Bmp4*-expressing region ([@bib31; @bib39]), and WNT pathway activation in the epiblast is required for primitive streak induction ([@bib18; @bib24; @bib28]). The spatiotemporal expression patterns of *Bmp4* and *Wnt3* are therefore consistent with a role for BMP4 in inducing *Wnt3* in the primitive streak-forming region. This is supported by the observations that BMP4 induces *Wnt3* expression in epiblast explants ([@bib2]), and *Bmp4* loss of function mutants fail to initiate gastrulation ([@bib52]). Since we find that WNT signals induce the essential gastrulation factors *Wnt3*, *Nodal*, and *Fgf8* in the epiblast, this suggests that, upon WNT3 induction, the primitive streak can continue to expand distally because of continuous induction of the gastrulation factors, including WNT3 itself, by WNT3.

A recent study shows that a subpopulation of EpiSCs expressing a transgenic *Brachyury* reporter displays reversible primitive streak characteristics, i.e., while biased toward mesoderm and endoderm fates, these cells retain their pluripotency ([@bib50]). In contrast, we find that a significant fraction of the cells labeled by our *Brachyury* reporter has lost pluripotency, as indicated by the inability to establish EpiSC colonies or to contribute to EBs. In support of this, our gene expression data indicate the presence of cells committed to a definitive endoderm fate in EpiSC cultures. The differences in our results may be explained by the *Brachyury* reporters used; the T-GFP reporter is targeted into the endogenous *Brachyury* locus and faithfully replicates its expression ([@bib12]). In contrast, the Tps/tb-RED reporter used by [@bib50] fails to recapitulate *Brachyury* expression in the anterior streak region which, importantly, is the source of definitive endoderm precursors ([@bib8]). Therefore, while the T-GFP-labeled population would include the cells that have lost pluripotency because they committed to a definitive endoderm state, the Tps/tb-RED reporter would not identify this population.

Recently, there has been debate about the nature of the trophoblast-committed cells induced by BMP4 in hESCs, with one study reporting that these cells represent a subpopulation of mesodermal cells that go through a BRACHYURY-positive state ([@bib3]). However, the absence of BRACHYURY and other mesendodermal and mesodermal markers in our BMP4+IWP2-differentiated trophoblast cells argues against a mesodermal character.

Experimental Procedures {#sec4}
=======================

Statistics {#sec4.1}
----------

All data are presented as mean ± SEM. Technical replicates are meant unless further specified; p values \< 0.05 determined using Student's t test were considered significant.

Cell Culture {#sec4.2}
------------

EpiSCs were cultured on gelatin and fetal calf serum-coated plates in N2B27 supplemented with 20 ng/ml ACTIVIN A and 12 ng/ml FGF2 (Peprotech). H1 and H9 hESCs were cultured on MEFs in Dulbecco's modified Eagle's medium/F12 supplemented with 20% knockout serum replacement and 10 ng/ml human FGF2 (Millipore). Feeder free culture was done on Matrigel (BD) in mTeSR1 medium (StemCell Technologies). Media, recombinant proteins, and small molecules were changed daily.

Animal Experiments {#sec4.3}
------------------

All animal experiments were conducted after approval by the Erasmus MC animal ethical committee.

Transcriptome Analysis {#sec4.4}
----------------------

Total RNA from GFP9 EpiSCs was prepared using TriPure (Roche), converted to biotin-labeled cRNA, hybridized to Affymetrix Mouse Genome 430 2.0 Arrays, and analyzed with the Affymetrix GeneChip Scanner 3000. RNA-Seq was performed at the Erasmus MC Center for Biomics using the Illumina HiSeq platform. We combined Illumina BeadArray gene expression data ([@bib25]) with our microarray data using a similar approach as described ([@bib21]). Microarray ([GSE62155](ncbi-geo:GSE62155){#intref0010}) and RNA-Seq ([GSE62205](ncbi-geo:GSE62205){#intref0015}) data are available in Gene Expression Omnibus (GEO). Further details are provided in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.
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========================

Document S1. Supplemental Experimental Procedures and Figures S1--S5Table S1. Genes Differentially Expressed between EpiSCs Maintained in the Presence or Absence of IWP2, Related to Figure 2This table uses a threshold value of 0.05 for false discovery rate-adjusted p value and a minimum fold change of 2. The list contains 515 probe sets representing 408 unique gene symbols.Table S2. Gene Set Enrichment Analysis for Gastrulation Markers in EpiSCs Maintained in the Absence versus the Presence of IWP2, Related to Figure 2Table S3. Gene Set Enrichment Analysis for Definitive Endoderm Markers in EpiSCs Maintained in the Absence versus the Presence of IWP2, Related to Figure 2Table S4. Gene Set Enrichment Analysis for Markers Expressed in Endoderm and Absent from Mesoderm and Ectoderm in EpiSCs Maintained in the Absence versus the Presence of IWP2, Related to Figure 2Table S5. Gene Set Enrichment Analysis for Markers Expressed in Mesoderm and Ectoderm and Absent from Endoderm in EpiSCs Maintained in the Absence versus the Presence of IWP2, Related to Figure 2Document S2. Article plus Supplemental Information
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![BMP4-Induced Differentiation of EpiSCs Depends on WNT Signals\
(A) Flow cytometry plots of T-GFP EpiSCs treated with the indicated factors and analyzed for T-GFP and SSEA1. The cells were maintained in the presence of IWP2 prior to the experiment. Line plots indicate the mean of three independent experiments ± SEM.\
(B) Axin2-LacZ EpiSCs treated for 3 days with the indicated factors and stained for LACZ (blue).\
(C) RT-PCR gene expression profiles of GFP9 EpiSCs treated for 2 days with the indicated factors, plotted relative to EpiSCs maintained in the presence of IWP2 (n = 3, mean ± SEM).\
(D) Principal component analysis of transcriptomes of GFP9 EpiSCs treated for 48 hr with the indicated factors or untreated (0 hr). The percentage of variance explained by the principal components is indicated between parentheses.\
(E) Heat map of selected gene expression levels in GFP9 EpiSCs treated for 48 hr with the indicated factors, determined by RNA-Seq.\
(F) Time course RT-PCR analysis of indicated genes in GFP9 EpiSCs following treatment with the indicated factors (n = 3, mean ± SEM).\
(G) Plot showing the expansion of OCT4- and SOX2-positive 129S2C1a EpiSCs in the indicated conditions (three independent experiments, mean ± SEM).\
The scale bar represents 200 μm. See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![Endogenous WNT Proteins Induce Loss of Pluripotency in EpiSCs\
(A) T-GFP EpiSCs were sorted into three categories based on GFP and assayed for their ability to establish NANOG-positive colonies (three independent experiments, mean ± SEM).\
(B) T-GFP EpiSCs were sorted into four categories based on GFP and assayed for their ability to establish EBs (top) or analyzed by flow cytometry for SOX2 and OCT4 (bottom, three independent experiments, mean ± SEM).\
(C) Flow cytometry histogram showing T-GFP EpiSCs treated for 3 days with the indicated factors and analyzed for SSEA1 (three independent experiments, mean ± SEM).\
(D) Real-time RT-PCR gene expression profiles of 129S2C1a EpiSCs cells treated for 3 days with IWP2, plotted relative to untreated EpiSCs (three independent experiments, mean ± SEM).\
(E) Scatter plot comparing the global gene expression levels of GFP9 EpiSCs cultured in the presence or absence of IWP2. The dotted lines delineate the boundaries of 2-fold difference in gene expression levels. Genes expressed more than 2-fold higher or lower in the presence of IWP2 are plotted in blue or red, respectively.\
(F) Gene set enrichment analysis plots demonstrating the enrichment of the indicated gene sets in EpiSCs cultured in the absence versus the presence of IWP2.\
(G) RT-PCR analysis for definitive endoderm genes in EpiSCs, in response to IWP2 (three biological replicates using 129S2C1a, Axin2LacZ, and GFP9 EpiSCs, mean ± SEM).\
Scale bar represents 200 μm. See also [Figure S2](#app2){ref-type="sec"}.](gr2){#fig2}

![WNT Inhibition Maintains EpiSCs in a Pregastrula Epiblast Stage\
(A) Transcriptomes from primary epiblasts dissected from embryos ranging from cavity to late bud stages and from the EpiSC line EpiSC9 were obtained from GEO ([GSE46227](ncbi-geo:GSE46227){#intref0025}) and combined with six microarray gene expression data sets from GFP9 EpiSCs cultured with and without IWP2 and analyzed by principal component analysis. The percentage of variance explained by the principal components is indicated between parentheses.\
(B) Reversal efficiency of T-GFP EpiSCs. Prior to start of the reversal experiment, the cells were maintained in the presence or absence of IWP2 as indicated (n = 3, mean ± SEM).\
(C) (Upper) X-gal stained chimeras derived from blastocyst injections of passage 5 Rosa26-LacZ EpiSCs. (Middle) Sections to indicate EpiSC contribution (blue). Asterisk indicates a nonchimeric littermate. (Lower) Chimera derived from blastocyst injections of passage 5 GFP9 EpiSCs. Green fluorescence indicates EpiSC contribution.\
(D) Heat map of selected gene expression levels of ESCs and GFP9 EpiSCs cultured in the presence or absence of IWP2 and analyzed by microarray.\
(E) E-CADHERIN and OCT4 immunofluorescence images of EpiSCs and ESCs.\
(F) RT-PCR for *E-cadherin* in EpiSCs and ESCs (three biological replicates using 129S2C1a, Axin2LacZ, and GFP9 EpiSCs, mean ± SEM).\
(G) Time course RT-PCR analysis of indicated genes in GFP9 EpiSCs following treatment with WNT3A (n = 3, mean ± SEM).\
(H) Real-time RT-PCR gene expression analysis of FVB EpiSCs relative to ESCs for a range of genes found by microarray to be differentially expressed between EpiSCs and ESCs (n = 3, mean ± SEM).\
(I) Flow cytometry histograms showing surface markers distinguishing ESCs (CD38, KIT, and ENDOGLIN) and EpiSCs (CD44).\
(J) OCT6 immunostaining (red) of 129S2C1a EpiSCs and ESCs (blue, DAPI).\
(K) The indicated ESC lines were aggregated into EBs and analyzed daily by flow cytometry for expression of reporter and the indicated cell surface markers (three independent experiments, mean ± SEM).\
Scale bar represents 1 mm (C, embryos), 200 μm (C, section), 100 μm (E and J). See also [Figure S3](#app2){ref-type="sec"}.](gr3){#fig3}

![Inhibition of Endogenous WNT Signals Prevents Accumulation of Differentiated Cells in hESC Cultures\
(A) H1 hESCs cultured for 5 days at the indicated conditions and stained for alkaline phosphatase (red). Arrows indicate differentiating areas of the colonies.\
(B) Flow cytometry histograms showing H1 hESCs cultured for 7 days in the presence or absence of IWP2 and analyzed for NANOG, OCT4, and SOX2 (three independent experiments, mean ± SEM).\
(C) Real-time RT-PCR gene expression profiles of H1 hESCs cultured for 6 days in the presence of IWP2, plotted relative to untreated cells (n = 3, mean ± SEM).\
(D) Percentage of H1 hESCs triple positive for NANOG, OCT4, and SOX2 in the indicated conditions and procedures (three independent experiments, mean ± SEM).\
(E) Percentage of H1 hESCs expressing SSEA1 in the indicated conditions and procedures (three independent experiments, mean ± SEM).\
Scale bar represents 500 μm. See also [Figure S4](#app2){ref-type="sec"}.](gr4){#fig4}

![BMP4 Induces Both WNT-Dependent and WNT-Independent Differentiation Pathways in hESCs\
(A) H1 hESCs were cultured with the indicated factors for 3 or 6 days and analyzed by flow cytometry for the mesodermal marker ROR2 (three independent experiments, mean ± SEM).\
(B) Real-time RT-PCR gene expression profiles of H1 hESCs cultured for 3 days in the indicated factors, plotted relative to cells maintained in the presence of IWP2 (n = 3, mean ± SEM).\
(C) *WNT3* expression level 6 hr after induction of H1 hESCs with the indicated factors, plotted relative to cells maintained in IWP2 (n = 3, mean ± SEM).\
(D) H1 hESCs cultured in the presence of the indicated factors and analyzed at several time points by flow cytometry for NANOG, OCT4, and SOX2. Plotted is the percentage of cells positive for all three markers (three independent experiments, mean ± SEM).\
(E) H1 hESCs cultured with the indicated factors for 3 or 6 days and analyzed by flow cytometry for the trophoblast marker APA (three independent experiments, mean ± SEM).\
(F) Real-time RT-PCR gene expression profiles of H1 hESCs cultured for 4 days in the indicated factors, plotted relative to cells maintained in the presence of IWP2 (n = 3, mean ± SEM).\
(G) H1 hESCs maintained in the presence or absence of IWP2 prior to the experiment were differentiated with BMP4 in the presence of IWP2 and analyzed by flow cytometry for the trophoblast marker APA (three independent experiments, mean ± SEM).\
See also [Figure S5](#app2){ref-type="sec"}.](gr5){#fig5}

![BMP and Endogenous WNT Signals Act Sequentially to Induce Shared and Distinct Differentiation Pathways in hESCs\
(Left to right) Endogenous WNT proteins induce differentiation toward primitive streak lineages (red), reducing self-renewal. BMP4 induces both trophoblast (dark blue) and, mediated by endogenous WNTs, primitive streak lineages. In the presence of WNT inhibitors, BMP4 induces only trophoblast and no primitive streak lineages. WNT signals upregulate gastrulation factors and induce primitive streak lineages. WNT inhibitors block spontaneous differentiation, obviating the need to remove differentiated cells during culture.](gr6){#fig6}
